Sahabuddin Ahmed

Dr. Sahabuddin Ahmed

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
Sahabuddin AhmedSahabuddin Ahmed
Sahabuddin Ahmed
MKMohit Kwatra
Mohit Kwatra
SPSamir Ranjan Panda
Samir Ranjan Panda
UMU.S.N Murty
U.S.N Murty
VNVGM Naidu
VGM Naidu

4 August 2016 in Inflammation
Verified
Journal Article
Closed access
PDF file
Sahabuddin AhmedSahabuddin Ahmed
Sahabuddin Ahmed
NMNitin Mundhe
Nitin Mundhe
MBManash Borgohain
Manash Borgohain
LCLiakat Chowdhury
Liakat Chowdhury
MKMohit Kwatra
Mohit Kwatra
MLMangala Lahkar
Mangala Lahkar

29 March 2016 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
Kundlik GadhaveKundlik Gadhave
Kundlik Gadhave
NBNityanand Bolshette
Nityanand Bolshette
AAAshutosh Ahire
Ashutosh Ahire
RPRohit Pardeshi
Rohit Pardeshi
KTKrishan K Thakur
Krishan K Thakur
MBMaria Balea
Maria Balea
The cellular quality control system degrades abnormal or misfolded proteins and consists of three different mechanisms: the ubiquitin proteasomal system (UPS), autophagy and molecular chaperones. Any disturbance in this system causes proteins to accumulate, resulting in neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer's disease (AD), Parkinson's disease, Huntington's disease and prion or polyglutamine diseases. Alzheimer's disease is currently one of the most common age‐related neurodegenerative diseases. However, its exact cause and pathogenesis are unknown. Currently approved medications for AD provide symptomatic relief; however, they fail to influence disease progression. Moreover, the components of the cellular quality control system represent an important focus for the development of targeted and potent therapies for managing AD. This review aims to evaluate whether existing evidence supports the hypothesis that UPS impairment causes the early pathogenesis of neurodegenerative disorders. The first part presents basic information about the UPS and its molecular components. The next part explains how the UPS is involved in neurodegenerative disorders. Finally, we emphasize how the UPS influences the management of AD. This review may help in the design of future UPS‐related therapies for AD.

1 November 2016 in European Journal of Pharmacology
Verified
Journal Article
Closed access
AJAshok Jangra
Ashok Jangra
MKMohit Kwatra
Mohit Kwatra
TSTavleen Singh
Tavleen Singh
RPRajat Pant
Rajat Pant
PKPawan Kushwah
Pawan Kushwah
MLMangala Lahkar
Mangala Lahkar

26 September 2022 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
KDKiran K. Dayananda
Kiran K. Dayananda
Sahabuddin AhmedSahabuddin Ahmed
Sahabuddin Ahmed
DWDaniel Wang
Daniel Wang
BPBaruh Polis
Baruh Polis
RIRafiad Islam
Rafiad Islam
AKArie Kaffman
Arie Kaffman
Early life adversity impairs normal hippocampal function and connectivity in various mammalian species, including humans and rodents. According to the 'cumulative model' the number of early adversities can be summed up to determine the risk for developing psychopathology later in life. In contrast, the 'dimensional model' argues that 'Deprivation' and 'Threat' impact different developmental processes that should not be added in determining clinical outcomes. Here we examine these predictions in male and female mice exposed to a single adversity - limited bedding (LB) - versus mice exposed to multiple adversities - unpredictable postnatal stress (UPS) - focusing on microglia-mediated synaptic pruning in the developing hippocampus. Exposure to both LB and UPS reduced the ramification of microglia, impaired their ability to phagocytose synaptic material in vivo and ex vivo, and decreased expression of TREM2. Abnormal phagocytic activity was associated with increased spine density in CA1 pyramidal neurons that was seen in 17-day-old groups and persisted in peri-pubescent 29-day-old LB and UPS mice. Exposure to LB caused more severe impairment in microglial ramification and synaptic engulfment compared to UPS, outcomes that were accompanied by a UPS-specific increase in the expression of several genes implicated in synaptic pruning. We propose that despite being a single stressor, LB represents a more severe form of early deprivation, and that appropriate levels of hippocampal stimulation during the second and third weeks of life are necessary to support normal microglial ramification and synaptic pruning. Further, impaired synaptic pruning during this critical period of hippocampal development contributes to the abnormal hippocampal function and connectivity seen in UPS and LB later in life.

17 July 2015 in Pharmaceutical Biology
Verified
Journal Article
Closed access
PDF file
MKMohit Kwatra
Mohit Kwatra
VKVikas Kumar
Vikas Kumar
AJAshok Jangra
Ashok Jangra
MMMurli Mishra
Murli Mishra
Sahabuddin AhmedSahabuddin Ahmed
Sahabuddin Ahmed
DKDr. RAZIA KHANAM
Dr. RAZIA KHANAM
Context: Doxorubicin (Dox) is one of the most active chemotherapeutic agents used to treat various types of cancers. Its clinical utility is compromised due to fatal cardiac toxicity characterized by an irreversible cardiomyopathy. Objective: This study evaluates the cardioprotective potential of naringin (NR) against Dox-induced acute cardiac toxicity in rats. Materials and methods: Male Wistar rats were randomly divided into five groups. NR (50 and 100 mg/kg) was administered intraperitoneally (i.p.) daily from 0 to 14 d. Doxorubicin (15 mg/kg, i.p.) was given as a single dose on the 10th day. On the 14th day, all animals were sacrificed and oxidative stress parameters that include malondialdehyde (MDA), glutathione (GSH) level, superoxide dismutase (SOD), catalase (CAT) activities, and all mitochondrial complexes (I-IV) activities were evaluated along with histopathological studies of the heart. Results: Doxorubicin-induced cardiotoxicity was confirmed by increased (p < 0.05) MDA, decreased (p < 0.05) GSH levels, SOD, and CAT activities, mitochondrial complexes (I–IV) activities in the heart tissue. NR (100 mg/kg) showed cardioprotection as evident from significant decreased MDA (p < 0.001) level, raised (p < 0.001) GSH level, SOD and CAT activities and increased mitochondrial complexes I (p < 0.01), II (p < 0.001), III (p < 0.001), and IV (p < 0.05) activities. Further, Dox-induced cardiotoxicity was confirmed by histopathological studies. These obtained results indicated the protective role of NR against Dox-induced cardiac toxicity in rats. Conclusion: NR can be used in combination with Dox due to its high cardioprotective effect against Dox-induced cardiomyopathy.